Cueto, Calixto M.
HRN: 14-52-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
METRONIDAZOLE 500MG (TAB)
04/29/2022
05/06/2022
PO
500mg
Tid
E. Histolytica
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes